Research Articles from Managed Care

Gary R. Bazalo, MS; Ashish V. Joshi, PhD; John Germak, MD
Payers' drug costs for human growth hormone are related to product waste that is related to the container in which the product is supplied
Meredith Y. Smith, PhD; Jerry Cromwell, PhD; Judith DePue, EdD; Bonnie Spring, PhD; William Redd, PhD; Marina Unrod, PhD
Jill Karpel, MD; Donald A. Bukstein, MD; Robert LoNigro, MD
Management of the uncontrolled asthma patient and case examples
Therese Zink, MD, MPH; Karen Lloyd, PhD, LP; George Isham, MD; David J. Mathews, PsyD, LICSW; Terry Crowson, MD
Implementing what was formerly called the Chronic Care Model can improve an organization's response to this widespread problem
Joseph Flood, MD, FACR; Charles Mihalik, PharmD, RPh; Renee R. Fleming, RPh, MBA; Bruce E. Strober, MD, PhD; Deborah R. Zucker, MD, PhD
Heinz Nagel, MD; Thomas Baehring, PhD; Werner A. Scherbaum, MD, PhD
Germany has been able to enroll more than a million people with type 2 diabetes in DM programs through legislation that created incentives for physicians and insurers
Joseph A. Caprini, MD, MS, FACS, RVT; Thomas M. Hyers, MD, FCCP
Deeply held, but not evidence-based, concerns about the possible risks of pharmacologic prophylaxis leave many patients at risk for DVT
Joseph R. Twanmoh, MD, FACEP; Gail P. Cunningham, MD, FACEP
Changing the process and mindset of health care professionals was the key to reducing emergency department overcrowding
Jordana K. Schmier, MA; Nancy J. Rachman, PhD; Michael T. Halpern, MD, PhD
Dietary supplementation with omega-3 fatty acids in U.S. males is associated with fewer cardiovascular fatalities and lower costs
David S. Geldmacher, MD
As with other chronic diseases of aging, early diagnosis and pharmacologic therapy may reduce the costs for enrollees with Alzheimer's disease

Pages